Fluid Biomed is a startup based in the United States, 1 tracked investor.
Fluid Biomed is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Fluid Biomed develops a novel polymer-metal hybrid flow-diverting stent designed to treat brain aneurysms by promoting blood vessel healing and reducing the risk of rupture and stroke through clinical investigation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.